1. Psoriatic arthritis due to nivolumab administration a case report and review of the literature
- Author
-
Konstantinos Sapalidis, Nikolaos V. Michalopoulos, Isaak Kesisoglou, Stylianos Mantalobas, Stella Laskou, Ilias Karapantzos, Chrysanthi Karapantzou, Alexandru Claudiu Munteanu, Crysanthi Sardeli, Charilaos Koulouris, Dimitrios Giannakidis, Christoforos Kosmidis, Dimitrios Drougas, Valeriu Surlin, Wolfgang Hohenforst-Schmidt, Paul Zarogoulidis, and Haidong Huang
- Subjects
PD-L1 ,Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,medicine.medical_treatment ,Arthritis ,Case Report ,Adenocarcinoma ,Targeted therapy ,03 medical and health sciences ,Psoriatic arthritis ,0302 clinical medicine ,Internal medicine ,Medicine ,Lung cancer ,Adverse effect ,Convex endobronchial ultrasound ,030203 arthritis & rheumatology ,lcsh:RC705-779 ,business.industry ,Immunotherapy ,lcsh:Diseases of the respiratory system ,respiratory system ,medicine.disease ,030220 oncology & carcinogenesis ,Nivolumab ,business - Abstract
Nowadays we have novel equipment for lung cancer diagnosis, however; due to lack of symptoms, lung cancer is still diagnosed at a late stage. Currently we have the following therapies for non-small cell lung cancer: a) non-specific cytotoxic agents, b) targeted therapies and c) immunotherapy. Each therapy has its own advantages and adverse effects. In the current case we will present a rare case of psoriacic arthritis that was presented after two cycles of nivolumab administration and we will also present a review of the literature. Keywords: Lung cancer, Adenocarcinoma, Convex endobronchial ultrasound, PD-L1, Targeted therapy
- Published
- 2018